{"id": "1369423291614642182", "creation": 1615330930.0, "user_id": "1254035253104181256", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "$VBIV VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902\nhttps://t.co/vhqXz6UK3K\n\n#vaccine #covid19", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19"]}